Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
2.500
-0.060 (-2.34%)
At close: Apr 1, 2025, 4:00 PM
2.650
+0.150 (6.00%)
After-hours: Apr 1, 2025, 4:48 PM EDT
Ensysce Biosciences Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Ensysce Biosciences.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Ensysce Biosciences.
Recommendation Trends
Rating | May '23 | Jun '23 | Jul '23 | Aug '23 | Sep '23 |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 2 | 2 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 2 | 2 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $135 → $105 | Strong Buy | Maintains | $135 → $105 | +4,100.00% | Sep 25, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $135 | Strong Buy | Initiates | $135 | +5,300.00% | Jul 3, 2023 |
Lake Street | Lake Street | Strong Buy Maintains $14,400 → $1,440 | Strong Buy | Maintains | $14,400 → $1,440 | +57,500.00% | Nov 17, 2022 |
Lake Street | Lake Street | Strong Buy Initiates $14,400 | Strong Buy | Initiates | $14,400 | +575,900.00% | Nov 30, 2021 |
Financial Forecast
Revenue This Year
n/a
from 5.21M
Revenue Next Year
47.76M
EPS This Year
-12.76
from -11.45
EPS Next Year
43.27
from -12.76
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | n/a | 84.0M | 91.7M |
Avg | n/a | 47.8M | 89.1M |
Low | n/a | 13.4M | 85.6M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | 92.0% |
Avg | - | - | 86.5% |
Low | - | - | 79.2% |
EPS Forecast
EPS | 2025 | 2026 |
---|---|---|
High | -10.71 | 44.54 |
Avg | -12.76 | 43.27 |
Low | -14.51 | 41.57 |
EPS Growth
EPS Growth | 2025 | 2026 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.